Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Neuroinflammation: Implications for Neurodegenerative Disease Treatment
Globular and homogeneous patterns may be seen
Morris, MD, FACC, FAHA, FASPC, FNLA, highlight key changes, including the incorporation of the American Heart Association PREVENT-ASCVD equations, updated LDL-C goals, expanded biomarker use (apoB, Lp(a)), and five new FDA-approved lipid-lowering therapies
Change in eGFR from baseline to each of the 180-, 360-, and 540-day time points was calculated
Results require maintenance and can be influenced by sun exposure, lifestyle, and skincare habits
Prescription medications obtained through a licensed clinician are generally FSA/HSA eligible, but compounded medications occupy a distinct regulatory category from FDA-approved drugs